News & Updates
Filter by Specialty:
Uniform threshold to rule out MI works well in male, female patients
A uniform cardiac troponin threshold to identify myocardial infarction (MI) risk demonstrates safety and efficacy in both male and female patients, reports a study.
Uniform threshold to rule out MI works well in male, female patients
14 May 2024
Septal LGE predicts major ventricular arrhythmia, cardiac death in cardiomyopathy
Late gadolinium enhancement (LGE) with septal location is significantly associated with major arrhythmic events among patients with dilated cardiomyopathy (DCM) and nondilated left ventricular (LV) cardiomyopathy (NDLVC), suggests a recent study.
Septal LGE predicts major ventricular arrhythmia, cardiac death in cardiomyopathy
13 May 2024
Solo ticagrelor after 1-month DAPT: Is it time to change practice?
Dropping aspirin for ticagrelor monotherapy 1 month after percutaneous coronary intervention (PCI) for acute coronary syndrome (ACS) is as good as dual antiplatelet therapy (DAPT) in the ULTIMATE-DAPT* trial presented at ACC.24.
Solo ticagrelor after 1-month DAPT: Is it time to change practice?
10 May 2024
GLP-1 RA plus SGLT-2i better than monotherapy for CV, renal events prevention
Patients with type 2 diabetes (T2D) who received combined treatment with glucagon-like peptide-1 receptor agonists (GLP-1 RA) and sodium-glucose cotransporter-2 inhibitors (SGLT-2i) have a much lower risk of major adverse cardiovascular events (MACE) and serious renal events than those treated with either drug class alone, suggests a recent study.